Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Hemostats And Tissue Sealants Market Heading Into 2029?

In the past few years, there has been a substantial growth in the market size of hemostats and tissue sealants. The market is projected to increase from $4.07 billion in 2024 to $4.35 billion in 2025, following a compound annual growth rate (CAGR) of 6.9%. The previous growth can be linked to factors such as the increasing older population, higher occurrences of accidents and trauma, a rising number of cardiovascular conditions, growing investments in the medical sector, and the escalating preference for minimally invasive surgeries.

The market for hemostats and tissue sealants is on course to experience robust expansion in the coming few years, with the valuation climbing to $5.61 billion in 2029, having a compound annual growth rate (CAGR) of 6.6%. Factors propelling this growth during the forecast period include the increasing utilization of hemostats in outpatient surgery facilities, surging demand for biocompatible and synthetic sealants, elevated investment in surgical innovations and R&D, heightened awareness regarding blood management in surgeries, and rising healthcare spendings. Key trends set to dominate the forecast period are the improvements in synthetic polymer technology, technological advancements in drug-delivery sealants, the incorporation of hemostatic agents in minimally invasive surgeries, progress in dual-action sealants and hemostats, and advancements in bioengineered and biocompatible materials.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Factors Are Pushing The Hemostats And Tissue Sealants Market Forward?

The growth of the hemostats and tissue sealants market is projected to be spurred by the increased number of surgical procedures. Surgical procedures are defined as medical operations that involve manual and instrumental techniques used by surgeons to diagnose, treat or remove diseased tissues or organs, or correct bodily functions. This increase in surgeries is primarily caused by the prevalence of chronic diseases that require surgical measures for successful management, treatment, or the prevention of complications. Hemostats and tissue sealants play a critical role in surgeries by effectively controlling bleeding and sealing tissues, which results in decreased complications and enhanced surgical results. For example, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization for board-certified aesthetic plastic surgeons, there was a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. Hence, the increased number of surgeries is propelling the growth of the hemostats and tissue sealants market.

Which Segment Held The Largest Share In The Hemostats And Tissue Sealants Market In 2025?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

How Are Key Trends Driving Expansion In The Hemostats And Tissue Sealants Industry?

Leading firms in the hemostat and tissue sealants market are now prioritizing the invention of enhanced products such as ready-to-use absorbable collagen pad hemostat to optimize efficiency and subsequent results in surgical procedures. This type of hemostat, made from biologically active, resorbable components, can be applied immediately without any prior preparation, providing an efficient mechanism for tissue and dura sealing alongside hemostasis. Specifically, Baxter International Inc., a healthcare company based in the United States, launched Hemopatch Sealing Hemostat with ambient temperature storage at a symposium held in Austria in April 2025. This novel room-temperature Hemopatch sealing hemostat eliminates the requirement for pre-warming, facilitating speedy application amid surgeries. This innovative absorbable pad could be employed directly in both open and minimally invasive procedures, obviating the requirement for product preparation or refrigeration. The robust adhesive attributes, extended lifespan, and prompt hemostatic impact of the product assist surgeons in managing leakage or bleeding more effectively. This contributes to improved surgical accuracy and patient recovery across a variety of specializations.

Which Organizations Are Driving Progress In The Hemostats And Tissue Sealants Industry?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Hemostats And Tissue Sealants Industry?

North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model